| Detected | Trial | Change |
|---|---|---|
| 2026-08-01 | NCT04518748 Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body… |
Enrollment closed, study ongoing |
| 2026-07-30 | NCT06580054 Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or… |
Enrollment closed, study ongoing |
| 2026-07-30 | NCT06580054 Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or… |
Enrollment reduced: 22 -> 3 participants |
| 2026-07-30 | NCT06580054 Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or… |
date change Primary completion moved earlier: 2028-03-01 -> 2026-12 |
| 2026-07-30 | NCT06580054 Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or… |
date change Completion moved earlier: 2030-03-01 -> 2026-12 |
| 2026-07-29 | NCT04140162 Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment… |
date change Completion pushed: 2026-05-02 -> 2026-09-02 |
| 2026-07-29 | NCT05911269 Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and… |
Trial completed |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-30 | NCT07737769 Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05183126 | Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With… | Breast Cancer | Recruiting |
| Phase 2 | |||
| NCT05038332 | Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known… | Prostate Cancer | Recruiting |
| NCT04858256 | Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms | T-Cell Neoplasm | Recruiting |
| NCT05894083 | A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at… | Oropharyngeal Cancer | Recruiting |
| NCT05901519 | A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic… | Hepatocellular Carcinoma | Recruiting |
| NCT07443943 | A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in… | Anatomic Stage 0 Breast Cancer AJCC v8 | Recruiting |
| NCT05956041 | Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell… | Cutaneous T Cell Lymphoma | Recruiting |
| NCT07158021 | Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT07094685 | Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck… | Advanced Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT06356155 | Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer | Urothelial Carcinoma | Recruiting |
| NCT06784336 | Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in… | Allogeneic Stem Cell Transplant | Recruiting |
| NCT03099356 | Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory… | Metastatic Thyroid Cancer | Recruiting |
| NCT07121595 | Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the… | Oral Cavity Squamous Cell Carcinoma | Recruiting |
| NCT03787680 | Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) | Prostate Cancer | Active, Not Recruiting |
| NCT04574856 | Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in… | Glioblastoma | Active, Not Recruiting |
| NCT04848337 | Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer | Prostate Cancer Metastatic | Active, Not Recruiting |
| NCT05988918 | Multicenter Trial of ESK981 in Patients With Select Solid Tumors | Pancreatic Adenocarcinoma | Active, Not Recruiting |
| NCT06234748 | Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer | Oropharynx Cancer | Active, Not Recruiting |
| NCT04748042 | Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy… | Prostate Cancer | Active, Not Recruiting |
| NCT04140162 | Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment… | Multiple Myeloma | Active, Not Recruiting |
| NCT06580054 | Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or… | Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06616155 | Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant… | Castration-Resistant Prostate Carcinoma | Recruiting |
| NCT06866262 | Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic… | Locally Advanced Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT03842696 | Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults… | Hematologic Diseases | Active, Not Recruiting |
| NCT04194554 | A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP… | Prostate Cancer | Active, Not Recruiting |